rs1555153828
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000020.3(ACVRL1):c.1313T>C(p.Met438Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000020.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACVRL1 | NM_000020.3 | c.1313T>C | p.Met438Thr | missense_variant | Exon 9 of 10 | ENST00000388922.9 | NP_000011.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 2 Pathogenic:2
The ACVRL1 c.1313T>C; p.Met438Thr variant is reported in the literature in at least one individual affected with hereditary hemorrhagic telangiectasia (HHT) (Letteboer 2005). This variant is reported in ClinVar (Variation ID: 533343), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The methionine at codon 438 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, other variants at this codon (c.1313T>G, p.Met438Arg; c.1313T>A, p.Met438Lys) have been reported in individuals with vascular anomalies (Mattassi 2018, McDonald 2011). Based on available information, the p.Met438Thr variant is considered to be likely pathogenic. References: Letteboer TG et al. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet. 2005 Jan;116(1-2):8-16. Mattassi R et al. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management. J Vasc Surg. 2018 Mar;67(3):922-932.e11. McDonald J et al. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis. Clin Genet. 2011 Apr;79(4):335-44. -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Met438 amino acid residue in ACVRL1. Other variant(s) that disrupt this residue have been observed in individuals with ACVRL1-related conditions (PMID: 21158752, 28655553), which suggests that this may be a clinically significant amino acid residue. This sequence change replaces methionine with threonine at codon 438 of the ACVRL1 protein (p.Met438Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 15517393, 31327192, Invitae). ClinVar contains an entry for this variant (Variation ID: 533343). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. -
ACVRL1-related disorder Pathogenic:1
The ACVRL1 c.1313T>C variant is predicted to result in the amino acid substitution p.Met438Thr. This variant was reported in an individual with hereditary hemorrhagic telangiectasia (HHT) (Letteboer et al. 2005. PubMed ID: 15517393). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In addition, other variants impacting the same amino acid (p.Met438Lys and p.Met438Arg) have also been reported in individuals with HHT (Mattassi et al. 2018. PubMed ID: 28655553; McDonald et al. 2010. PubMed ID: 21158752). Based on this evidence, we interpret the c.1313T>C (p.Met438Thr) variant as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at